PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study
MetX funded by $1M grant from Metrodora Foundation to accelerate research for complex multisystem disorders
SALT LAKE CITY, UT and OXFORD, UK – 18 September 2024 – PrecisionLife, a leading clinical-stage precision medicine company focused on chronic diseases, and Metrodora Institute, an advanced US research and healthcare center, have begun sharing the first research results with participants from Metrodora’s MetX study.